Bioinformatics Market by Product & Service (Knowledge Management Tools, Data Analysis Platforms, Structural Analysis, Functional Analysis, Services), Applications (Genomics, Proteomics), & Sector (Medical, Animal, Agricultural) – Global Forecast to 2026

世界のバイオインフォマティクス市場予測(~2026):製品・サービス別、用途別、産業別

◆タイトル:Bioinformatics Market by Product & Service (Knowledge Management Tools, Data Analysis Platforms, Structural Analysis, Functional Analysis, Services), Applications (Genomics, Proteomics), & Sector (Medical, Animal, Agricultural) – Global Forecast to 2026
◆商品コード:HIT7543
◆調査・発行会社:MarketsandMarkets
◆発行日:2021年9月28日
◆ページ数:221
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥564,300見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥758,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥929,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

マーケッツアンドマーケッツ社はバイオインフォマティクスの世界市場規模が2021年107億ドルから2026年218億ドルまで、年平均15.2%成長すると予想しています。本調査レポートでは、世界のバイオインフォマティクス市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、製品・サービス別(ナレッジマネジメントツール、バイオインフォマティクスプラットフォーム、バイオインフォマティクスサービス)分析、セクター別(医療バイオテクノロジー、動物バイオテクノロジー、植物バイオテクノロジー、環境バイオテクノロジー、法医学バイオテクノロジー)分析、用途別(ゲノミクス、ケモインフォマティクス&ドラッグデザイン、プロテオミクス、トランスクリプトミクス、メタボロミクス)分析、地域別分析、競争状況、企業情報などを掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場動向
・バイオインフォマティクスの世界市場規模:製品・サービス別(ナレッジマネジメントツール、バイオインフォマティクスプラットフォーム、バイオインフォマティクスサービス)
・バイオインフォマティクスの世界市場規模:セクター別(医療バイオテクノロジー、動物バイオテクノロジー、植物バイオテクノロジー、環境バイオテクノロジー、法医学バイオテクノロジー)
・バイオインフォマティクスの世界市場規模:用途別(ゲノミクス、ケモインフォマティクス&ドラッグデザイン、プロテオミクス、トランスクリプトミクス、メタボロミクス)
・バイオインフォマティクスの世界市場規模:地域別
・競争状況
・企業情報

“The global bioinformatics market is projected to reach USD 21.8 billion by 2026 from USD 10.7 billion in 2021, at a CAGR of 15.2% during the forecast period.”
Bioinformatics is the application of computer technology for the management and analysis of biological data. It includes storage, analysis, and dissemination of biological data. Bioinformatics uses computer programs for a variety of applications, including determining gene & protein functions, establishing evolutionary relationships, and predicting the three-dimensional shapes of proteins. However, high costs of bioinformatics software and services and a dearth of skilled professionals are likely to challenge market growth in the coming years.

“Medical biotechnology to hold thelargestsegmentof the market.”
Based on the sector, the market is segmented into medical biotechnology, animal biotechnology, plant biotechnology, environmental biotechnology, forensic biotechnology, another sector. The medical biotechnology segment accounted for the largest share of 50.3% of the bioinformatics market in 2020.The development of new databases for drug discovery, the use of bioinformatics for clinical diagnostics, and the increased funding for the development of bioinformatics solutions for clinical diagnostics are primarily driving the use of bioinformatics in clinical diagnostics and contributing to the growth of the medical biotechnology segment in the market.

“Genomics segment to hold the largest share of the component market.”
Based on application, the bioinformatics market is segmented into genomics, chemoinformatics& drug design, proteomics, transcriptomics, metabolomics, and other applications. The genomics segment accounted for the largest market share of 36.9% in 2020. The increasing use of pharmacogenomic research for the development of precision medicine, the growing favorable funding scenario for genomic research, and the increasing partnerships and collaborations between various life sciences and informatics companies for the development of advanced bioinformatics tools and software are the major factors contributing to the growth of the bioinformatics market for genomics.

“The US to dominate thebioinformatics market in North America.”
North America dominated the bioinformatics market, with a share of 45.0% in 2020, followed by Europe and the Asia Pacific, and Rest of World. North America has been among the frontrunners in developing bioinformatics services in the healthcare industry. The bioinformatics market in the US is expected to offer growth opportunities in the coming years owing to the increasing incorporation of EHR in the hospitals. Many major global players are also based in the US, owing to which the country has become a center of innovation in the bioinformatics market.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1 – 45%, Tier 2 – 40%, and Tier 3 – 15%
• By Designation:Director-level – 30%, C-level – 41%, and Others – 29%
• By Region: North America – 36%, Europe – 30%, APAC –21%, Rest of the World –13%

Some of the prominent players operating in the bioinformatics market areThermo Fisher Scientific, Inc. (US), Eurofins Scientific (Luxembourg), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), and Illumina, Inc. (US), Waters Corporation (US), DNASTAR (US), NeoGenomics Laboratories (US), Perkin Elmer, Inc. (US), GENEWIZ (US) and BGI Group (China) Waters Corporation (US), DNASTAR (US), NeoGenomics Laboratories (US), Perkin Elmer, Inc. (US), GENEWIZ (US) and BGI Group (China), Fios Genomics (UK), Partek Incorporated (US), SOPHiA Genetics (Switzerland), Source BioScience (UK), and Biomax Informatics AG (Germany) among others.

Research Coverage
This report studies the bioinformatics market based on products & services, sector, and application, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to two main geographies – source and destination.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

【レポートの目次】

1 INTRODUCTION 31
1.1 OBJECTIVES OF THE STUDY 31
1.2 MARKET DEFINITION 31
1.3 MARKET SCOPE 32
1.3.1 INCLUSIONS & EXCLUSIONS 32
1.3.2 MARKETS COVERED 32
1.3.3 YEARS CONSIDERED FOR THE STUDY 33
1.4 CURRENCY 33
1.5 LIMITATIONS 33
1.6 STAKEHOLDERS 33
1.7 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 1 RESEARCH DESIGN 35
2.1.1 SECONDARY SOURCES 36
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY SOURCES 37
FIGURE 2 PRIMARY SOURCES 37
2.1.2.1 Key data from primary sources 38
FIGURE 3 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE,
DESIGNATION, AND REGION 38
2.2 MARKET SIZE ESTIMATION 39
FIGURE 4 BIOINFORMATICS MARKET: REVENUE MAPPING-BASED MARKET ESTIMATION (BOTTOM-UP APPROACH) 39
FIGURE 5 CAGR PROJECTIONS: BIOINFORMATICS MARKET 40
FIGURE 6 BIOINFORMATICS MARKET: TOP-DOWN APPROACH 41
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 42
FIGURE 7 DATA TRIANGULATION METHODOLOGY 42
2.4 MARKET PLAYER RANKING 43
2.5 ASSUMPTIONS FOR THE STUDY 43
2.6 RISK ANALYSIS 43
3 EXECUTIVE SUMMARY 44
FIGURE 8 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2020 VS. 2026 (USD MILLION) 44
FIGURE 9 BIOINFORMATICS MARKET, BY SECTOR, 2020 VS. 2026 (USD MILLION) 45
FIGURE 10 BIOINFORMATICS MARKET, BY APPLICATION, 2020 VS. 2026 (USD MILLION) 45

4 PREMIUM INSIGHTS 47
4.1 BIOINFORMATICS MARKET OVERVIEW 47
FIGURE 11 GROWING APPLICATIONS OF BIOINFORMATICS IS A KEY FACTOR EXPECTED TO DRIVE THE MARKET GROWTH DURING THE FORECAST PERIOD 47
4.2 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE 48
FIGURE 12 KNOWLEDGE MANAGEMENT TOOLS SEGMENT TO DOMINATE
THE BIOINFORMATICS MARKET BY 2026 48
4.3 BIOINFORMATICS MARKET: GEOGRAPHIC MIX 48
FIGURE 13 INDIA TO WITNESS THE HIGHEST GROWTH RATE DURING
THE FORECAST PERIOD 48
4.4 BIOINFORMATICS MARKET: REGIONAL MIX 49
FIGURE 14 NORTH AMERICA DOMINATED THE MARKET IN 2020 49
5 MARKET OVERVIEW 50
5.1 INTRODUCTION 50
5.2 MARKET DYNAMICS 50
FIGURE 15 BIOINFORMATICS MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 50
5.2.1 DRIVERS 51
5.2.1.1 Increasing public-private sector funding for bioinformatics 51
TABLE 1 PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS AND
RELATED FIELDS 51
5.2.1.2 Increasing demand for personalized medicine 53
5.2.1.3 Increasing pharmaceutical and biotechnology R&D expenditure 53
TABLE 2 R&D INVESTMENTS BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN THE ASIA PACIFIC REGION 54
5.2.1.4 Decreasing costs of genome sequencing 54
5.2.2 RESTRAINTS 55
5.2.2.1 High equipment costs 55
5.2.3 OPPORTUNITIES 56
5.2.3.1 Lucrative opportunities in emerging markets 56
5.2.3.2 Adoption of blockchain technology and cloud computing 56
5.2.3.3 Integration of machine learning and AI in healthcare 56
5.2.3.4 Investments by leading IT companies in the development of bioinformatics solutions 57
5.2.4 CHALLENGES 57
5.2.4.1 Management of large data volumes 57
5.2.4.2 Lack of interoperability and multiplatform capabilities 58
5.2.4.3 Growing competition from in-house development and publicly available tools 58
5.2.4.4 Shortage of skilled bioinformatics professionals 59
5.3 PORTER’S FIVE FORCES ANALYSIS 59
5.3.1 THREAT OF NEW ENTRANTS 60
5.3.2 BARGAINING POWER OF SUPPLIERS 60
5.3.3 BARGAINING POWER OF BUYERS 60
5.3.4 THREAT OF SUBSTITUTES 60
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 60
5.4 VALUE CHAIN ANALYSIS 61
FIGURE 16 VALUE CHAIN ANALYSIS: BIOINFORMATICS MARKET 61
5.4.1 RESEARCH AND DEVELOPMENT (R&D) 61
5.4.2 RAW MATERIAL 61
5.4.3 DISTRIBUTION AND AFTER-SALES SERVICES 61
5.5 REGULATORY LANDSCAPE 62
5.5.1 GLOBAL ALLIANCE FOR GENOMICS AND HEALTH (GA4GH) 62
5.6 CASE STUDIES 63
5.7 IMPACT OF COVID-19 ON THE BIOINFORMATICS MARKET 63
5.8 ECOSYSTEM/MARKET MAP 64
TABLE 3 BIOINFORMATICS MARKET: ECOSYSTEM 64
6 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE 65
6.1 INTRODUCTION 66
TABLE 4 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 66
6.2 KNOWLEDGE MANAGEMENT TOOLS 66
TABLE 5 KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,
2019–2026 (USD MILLION) 67
TABLE 6 KNOWLEDGE MANAGEMENT TOOLS MARKET, BY REGION,
2019–2026 (USD MILLION) 67
TABLE 7 NORTH AMERICA: KNOWLEDGE MANAGEMENT TOOLS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 67
TABLE 8 EUROPE: KNOWLEDGE MANAGEMENT TOOLS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 68
TABLE 9 APAC: KNOWLEDGE MANAGEMENT TOOLS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 68
6.2.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS 68
6.2.1.1 Development of novel standard generalized knowledge management tools to drive market growth 68
TABLE 10 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS MARKET, BY REGION, 2019–2026 (USD MILLION) 69
6.2.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS 69
6.2.2.1 Data security and highly reliable information storage system to support specialized knowledge management tools segment 69
TABLE 11 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS MARKET, BY REGION, 2019–2026 (USD MILLION) 70
6.3 BIOINFORMATICS PLATFORMS 70
TABLE 12 BIOINFORMATICS PLATFORMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 70
TABLE 13 BIOINFORMATICS PLATFORMS MARKET, BY REGION,
2019–2026 (USD MILLION) 71
TABLE 14 NORTH AMERICA: BIOINFORMATICS PLATFORMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 71
TABLE 15 EUROPE: BIOINFORMATICS PLATFORMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 71
TABLE 16 APAC: BIOINFORMATICS PLATFORMS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 72
6.3.1 DATA ANALYSIS PLATFORMS 72
6.3.1.1 Increasing need for data analysis during sequencing programs to drive the growth of the segment 72
TABLE 17 DATA ANALYSIS PLATFORMS MARKET, BY REGION,
2019–2026 (USD MILLION) 72
6.3.2 STRUCTURAL & FUNCTIONAL ANALYSIS PLATFORMS 73
6.3.2.1 Growing proteomics research worldwide to drive the adoption of structural & functional analysis platforms 73
TABLE 18 STRUCTURAL & FUNCTIONAL ANALYSIS PLATFORMS MARKET, BY REGION, 2019–2026 (USD MILLION) 73
6.3.3 OTHER BIOINFORMATICS PLATFORMS 74
6.3.3.1 Growing need for DNA and protein sequencing in life science sectors to drive the growth of other bioinformatics platforms 74
TABLE 19 OTHER BIOINFORMATICS PLATFORMS MARKET, BY REGION,
2019–2026 (USD MILLION) 74
6.4 BIOINFORMATICS SERVICES 74
TABLE 20 BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 75
TABLE 21 BIOINFORMATICS SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 75
TABLE 22 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 75
TABLE 23 EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 76
TABLE 24 APAC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 76
6.4.1 SEQUENCING SERVICES 76
6.4.1.1 Financial support from the government and private bodies to drive the growth of the segment 76
TABLE 25 SEQUENCING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 77
TABLE 26 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 77
TABLE 27 EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 77
TABLE 28 APAC: SEQUENCING SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 78
6.4.2 DATA ANALYSIS SERVICES 78
6.4.2.1 Growing adoption of big data analytics in life science research to drive market growth 78
TABLE 29 DATA ANALYSIS SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 79
TABLE 30 NORTH AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 79
TABLE 31 EUROPE: DATA ANALYSIS SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 79
TABLE 32 APAC: DATA ANALYSIS SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 80
6.4.3 DRUG DISCOVERY SERVICES 80
6.4.3.1 Growing technological advancements in pharmacogenomics and increasing collaborations between pharmaceutical companies to drive market growth 80
TABLE 33 DRUG DISCOVERY SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 80
TABLE 34 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 81
TABLE 35 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 81
TABLE 36 APAC: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 81
6.4.4 DIFFERENTIAL GENE EXPRESSION ANALYSIS SERVICES 82
6.4.4.1 Increasing R&D for the advancement of solutions and services for differential gene expression studies to drive market growth 82
TABLE 37 DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET, BY REGION,
2019–2026 (USD MILLION) 82
TABLE 38 NORTH AMERICA: DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 82
TABLE 39 EUROPE: DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 83
TABLE 40 APAC: DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 83
6.4.5 DATABASE AND MANAGEMENT SERVICES 83
6.4.5.1 Growing amount of data generated to increase the need for database and management services 83
TABLE 41 DATABASE AND MANAGEMENT SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 84
TABLE 42 NORTH AMERICA: DATABASE AND MANAGEMENT SERVICES MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 84
TABLE 43 EUROPE: DATABASE AND MANAGEMENT SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 84
TABLE 44 APAC: DATABASE AND MANAGEMENT SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 85
6.4.6 OTHER BIOINFORMATICS SERVICES 85
TABLE 45 OTHER BIOINFORMATICS SERVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 85
TABLE 46 NORTH AMERICA: OTHER BIOINFORMATICS SERVICES, BY COUNTRY,
2019–2026 (USD MILLION) 85
TABLE 47 EUROPE: OTHER BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 86
TABLE 48 APAC: OTHER BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 86

7 BIOINFORMATICS MARKET, BY SECTOR 87
7.1 INTRODUCTION 88
TABLE 49 BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION) 88
7.2 MEDICAL BIOTECHNOLOGY 88
TABLE 50 BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY SECTOR, 2019–2026 (USD MILLION) 89
TABLE 51 BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY REGION, 2019–2026 (USD MILLION) 89
TABLE 52 NORTH AMERICA: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY COUNTRY, 2019–2026 (USD MILLION) 89
TABLE 53 EUROPE: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY,
BY COUNTRY, 2019–2026 (USD MILLION) 90
TABLE 54 APAC: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY,
BY COUNTRY, 2019–2026 (USD MILLION) 90
7.2.1 DRUG DISCOVERY & DEVELOPMENT 90
7.2.1.1 Increasing adoption of bioinformatics services and products for
drug designing to drive the segment growth 90
TABLE 55 BIOINFORMATICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,
BY REGION, 2019–2026 (USD MILLION) 91
7.2.2 CLINICAL DIAGNOSTICS & PERSONALIZED MEDICINE 91
7.2.2.1 Presence of research groups engaged in the development of bioinformatics tools for personalized medicine to
propel market growth 91
TABLE 56 BIOINFORMATICS MARKET FOR CLINICAL DIAGNOSTICS & PERSONALIZED MEDICINE, BY REGION, 2019–2026 (USD MILLION) 92
7.2.3 REPRODUCTIVE HEALTH 92
7.2.3.1 Increasing research and development in the field of reproductive health to bolster market growth in the segment 92
TABLE 57 BIOINFORMATICS MARKET FOR REPRODUCTIVE HEALTH, BY REGION,
2019–2026 (USD MILLION) 93
7.3 ANIMAL BIOTECHNOLOGY 93
7.3.1 RAPID ADVANCES IN THE UNDERSTANDING OF FARM ANIMAL GENOMES TO AID MARKET GROWTH 93
TABLE 58 BIOINFORMATICS MARKET FOR ANIMAL BIOTECHNOLOGY, BY REGION, 2019–2026 (USD MILLION) 94
TABLE 59 NORTH AMERICA: BIOINFORMATICS MARKET FOR ANIMAL BIOTECHNOLOGY, BY COUNTRY, 2019–2026 (USD MILLION) 94
TABLE 60 EUROPE: BIOINFORMATICS MARKET FOR ANIMAL BIOTECHNOLOGY,
BY COUNTRY, 2019–2026 (USD MILLION) 94
TABLE 61 APAC: BIOINFORMATICS MARKET FOR ANIMAL BIOTECHNOLOGY,
BY COUNTRY, 2019–2026 (USD MILLION) 95
7.4 PLANT BIOTECHNOLOGY 95
7.4.1 INCREASED USE OF BIOINFORMATICS FOR TIME AND COST-EFFICIENT
R&D IN AGRICULTURE TO DRIVE MARKET GROWTH 95
TABLE 62 BIOINFORMATICS MARKET FOR PLANT BIOTECHNOLOGY, BY REGION,
2019–2026 (USD MILLION) 96
TABLE 63 NORTH AMERICA: BIOINFORMATICS MARKET FOR PLANT BIOTECHNOLOGY, BY COUNTRY, 2019–2026 (USD MILLION) 96
TABLE 64 EUROPE: BIOINFORMATICS MARKET FOR PLANT BIOTECHNOLOGY,
BY COUNTRY, 2019–2026 (USD MILLION) 96
TABLE 65 APAC: BIOINFORMATICS MARKET FOR PLANT BIOTECHNOLOGY,
BY COUNTRY, 2019–2026 (USD MILLION) 97
7.5 ENVIRONMENTAL BIOTECHNOLOGY 97
7.5.1 INCREASING USE OF NGS FOR ENVIRONMENTAL BIOTECHNOLOGY APPLICATIONS TO DRIVE THE MARKET GROWTH 97
TABLE 66 BIOINFORMATICS MARKET FOR ENVIRONMENTAL BIOTECHNOLOGY,
BY REGION, 2019–2026 (USD MILLION) 98
TABLE 67 NORTH AMERICA: BIOINFORMATICS MARKET FOR ENVIRONMENTAL BIOTECHNOLOGY, BY COUNTRY, 2019–2026 (USD MILLION) 98
TABLE 68 EUROPE: BIOINFORMATICS MARKET FOR ENVIRONMENTAL BIOTECHNOLOGY, BY COUNTRY, 2019–2026 (USD MILLION) 98
TABLE 69 APAC: BIOINFORMATICS MARKET FOR ENVIRONMENTAL BIOTECHNOLOGY, BY COUNTRY, 2019–2026 (USD MILLION) 99
7.6 FORENSIC BIOTECHNOLOGY 99
7.6.1 INCREASING AVAILABILITY OF ADVANCED SOFTWARE FOR INVESTIGATIONAL PURPOSES TO DRIVE THE GROWTH OF THE SEGMENT 99
TABLE 70 BIOINFORMATICS MARKET FOR FORENSIC BIOTECHNOLOGY, BY REGION, 2019–2026 (USD MILLION) 100
TABLE 71 NORTH AMERICA: BIOINFORMATICS MARKET FOR FORENSIC BIOTECHNOLOGY, BY COUNTRY, 2019–2026 (USD MILLION) 100
TABLE 72 EUROPE: BIOINFORMATICS MARKET FOR FORENSIC BIOTECHNOLOGY,
BY COUNTRY, 2019–2026 (USD MILLION) 100
TABLE 73 APAC: BIOINFORMATICS MARKET FOR FORENSIC BIOTECHNOLOGY,
BY COUNTRY, 2019–2026 (USD MILLION) 101
7.7 OTHER SECTORS 101
TABLE 74 BIOINFORMATICS MARKET FOR OTHER SECTORS, BY REGION,
2019–2026 (USD MILLION) 102
TABLE 75 NORTH AMERICA: BIOINFORMATICS MARKET FOR OTHER SECTORS,
BY COUNTRY, 2019–2026 (USD MILLION) 102
TABLE 76 EUROPE: BIOINFORMATICS MARKET FOR OTHER SECTORS, BY COUNTRY, 2019–2026 (USD MILLION) 102
TABLE 77 APAC: BIOINFORMATICS MARKET FOR OTHER SECTORS, BY COUNTRY, 2019–2026 (USD MILLION) 103
8 BIOINFORMATICS MARKET, BY APPLICATION 104
8.1 INTRODUCTION 105
TABLE 78 BIOINFORMATICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 105
8.2 GENOMICS 105
8.2.1 DECREASING COST OF NEXT-GENERATION SEQUENCING TO
DRIVE THE GENOMICS SEGMENT 105
TABLE 79 GENOMICS MARKET, BY REGION, 2019–2026 (USD MILLION) 106
8.3 CHEMOINFORMATICS & DRUG DESIGN 106
8.3.1 GROWING USE IN DRUG DESIGNING PROCESS BY PHARMACEUTICAL COMPANIES TO DRIVE CHEMOINFORMATICS SEGMENT 106
TABLE 80 CHEMOINFORMATICS & DRUG DESIGN MARKET, BY REGION,
2019–2026 (USD MILLION) 106
8.4 PROTEOMICS 107
8.4.1 INCREASING APPLICATIONS IN DRUG DISCOVERY TO DRIVE THE PROTEOMICS MARKET 107
TABLE 81 PROTEOMICS MARKET, BY REGION, 2019–2026 (USD MILLION) 107
8.5 TRANSCRIPTOMICS 108
8.5.1 TRANSCRIPTOMICS TO REGISTER THE HIGHEST CAGR
DURING THE FORECAST PERIOD 108
TABLE 82 TRANSCRIPTOMICS MARKET, BY REGION, 2019–2026 (USD MILLION) 108
8.6 METABOLOMICS 108
8.6.1 INCREASING RESEARCH FUNDING TO DRIVE THE METABOLOMICS SEGMENT 108
TABLE 83 METABOLOMICS MARKET, BY REGION, 2019–2026 (USD MILLION) 109
8.7 OTHER APPLICATIONS 109
8.7.1 OTHER APPLICATIONS TO DRIVE RESEARCH IN THE
BIOINFORMATICS MARKET 109
TABLE 84 OTHER APPLICATIONS MARKET, BY REGION, 2019–2026 (USD MILLION) 110
9 BIOINFORMATICS MARKET, BY REGION 111
9.1 INTRODUCTION 112
TABLE 85 BIOINFORMATICS MARKET, BY REGION, 2019–2026 (USD MILLION) 112
9.2 NORTH AMERICA 112
FIGURE 17 NORTH AMERICA: BIOINFORMATICS MARKET SNAPSHOT (2020) 113
TABLE 86 NORTH AMERICA: BIOINFORMATICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 114
TABLE 87 NORTH AMERICA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 114
TABLE 88 NORTH AMERICA: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2019–2026 (USD MILLION) 114
TABLE 89 NORTH AMERICA: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 114
TABLE 90 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 115
TABLE 91 NORTH AMERICA: BIOINFORMATICS MARKET, BY SECTOR,
2019–2026 (USD MILLION) 115
TABLE 92 NORTH AMERICA: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2019–2026 (USD MILLION) 115
TABLE 93 NORTH AMERICA: BIOINFORMATICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 116
9.2.1 US 116
9.2.1.1 The US dominated the North American market in 2020 116
TABLE 94 US: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 117
TABLE 95 US: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2019–2026 (USD MILLION) 117
TABLE 96 US: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 117
TABLE 97 US: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 118
TABLE 98 US: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION) 118
TABLE 99 US: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2019–2026 (USD MILLION) 118
TABLE 100 US: BIOINFORMATICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 119
9.2.2 CANADA 119
9.2.2.1 Growth in the genomics field to drive the bioinformatics
market in Canada 119
TABLE 101 CANADA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 120
TABLE 102 CANADA: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 120
TABLE 103 CANADA: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 120
TABLE 104 CANADA: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 121
TABLE 105 CANADA: BIOINFORMATICS MARKET, BY SECTOR,
2019–2026 (USD MILLION) 121
TABLE 106 CANADA: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY,
BY TYPE, 2019–2026 (USD MILLION) 121
TABLE 107 CANADA: BIOINFORMATICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 122
9.3 EUROPE 122
FIGURE 18 EUROPE: BIOINFORMATICS MARKET SNAPSHOT (2020) 123
TABLE 108 EUROPE: BIOINFORMATICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 124
TABLE 109 EUROPE: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 124
TABLE 110 EUROPE: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 124
TABLE 111 EUROPE: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 112 EUROPE: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 113 EUROPE: BIOINFORMATICS MARKET, BY SECTOR,
2019–2026 (USD MILLION) 125
TABLE 114 EUROPE: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY,
BY TYPE, 2019–2026 (USD MILLION) 126
TABLE 115 EUROPE: BIOINFORMATICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 126
9.3.1 GERMANY 126
9.3.1.1 Germany is the largest market for bioinformatics products and services in Europe 126
TABLE 116 GERMANY: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 127
TABLE 117 GERMANY: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2019–2026 (USD MILLION) 127
TABLE 118 GERMANY: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 127
TABLE 119 GERMANY: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 128
TABLE 120 GERMANY: BIOINFORMATICS MARKET, BY SECTOR,
2019–2026 (USD MILLION) 128
TABLE 121 GERMANY: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY,
BY TYPE, 2019–2026 (USD MILLION) 128
TABLE 122 GERMANY: BIOINFORMATICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 129
9.3.2 UK 129
9.3.2.1 Increasing genomics research to drive market growth in the UK 129
TABLE 123 UK: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 129
TABLE 124 UK: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2019–2026 (USD MILLION) 130
TABLE 125 UK: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 130
TABLE 126 UK: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 130
TABLE 127 UK: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION) 131
TABLE 128 UK: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2019–2026 (USD MILLION) 131
TABLE 129 UK: BIOINFORMATICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 131
9.3.3 FRANCE 132
9.3.3.1 Government initiatives for genomics research to drive
market growth in France 132
TABLE 130 FRANCE: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 132
TABLE 131 FRANCE: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 132
TABLE 132 FRANCE: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 133
TABLE 133 FRANCE: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 133
TABLE 134 FRANCE: BIOINFORMATICS MARKET, BY SECTOR,
2019–2026 (USD MILLION) 133
TABLE 135 FRANCE: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY,
BY TYPE, 2019–2026 (USD MILLION) 134
TABLE 136 FRANCE: BIOINFORMATICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 134
9.3.4 ITALY 134
9.3.4.1 Increasing research in genomics to drive market growth in Italy 134
TABLE 137 ITALY: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 135
TABLE 138 ITALY: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 135
TABLE 139 ITALY: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 135
TABLE 140 ITALY: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 136
TABLE 141 ITALY: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION) 136
TABLE 142 ITALY: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2019–2026 (USD MILLION) 136
TABLE 143 ITALY: BIOINFORMATICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 137
9.3.5 SPAIN 137
9.3.5.1 Presence of several local players in the Spanish bioinformatics market to drive market growth 137
TABLE 144 SPAIN: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 137
TABLE 145 SPAIN: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 138
TABLE 146 SPAIN: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 147 SPAIN: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 148 SPAIN: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION) 139
TABLE 149 SPAIN: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2019–2026 (USD MILLION) 139
TABLE 150 SPAIN: BIOINFORMATICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 139
9.3.6 ROE 140
TABLE 151 ROE: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 140
TABLE 152 ROE: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 140
TABLE 153 ROE: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 141
TABLE 154 ROE: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 141
TABLE 155 ROE: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION) 141
TABLE 156 ROE: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2019–2026 (USD MILLION) 142
TABLE 157 ROE: BIOINFORMATICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 142
9.4 ASIA PACIFIC 142
FIGURE 19 ASIA PACIFIC: BIOINFORMATICS MARKET SNAPSHOT (2020) 143
TABLE 158 ASIA PACIFIC: BIOINFORMATICS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 143
TABLE 159 ASIA PACIFIC: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 144
TABLE 160 ASIA PACIFIC: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2019–2026 (USD MILLION) 144
TABLE 161 ASIA PACIFIC: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 144
TABLE 162 ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 145
TABLE 163 ASIA PACIFIC: BIOINFORMATICS MARKET, BY SECTOR,
2019–2026 (USD MILLION) 145
TABLE 164 ASIA PACIFIC: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2019–2026 (USD MILLION) 145
TABLE 165 ASIA PACIFIC: BIOINFORMATICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 146
9.4.1 CHINA 146
9.4.1.1 Partnerships and collaborations between various industry stakeholders are driving the development of bioinformatics in China 146
TABLE 166 CHINA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 147
TABLE 167 CHINA: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 147
TABLE 168 CHINA: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 147
TABLE 169 CHINA: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 148
TABLE 170 CHINA: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION) 148
TABLE 171 CHINA: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2019–2026 (USD MILLION) 148
TABLE 172 CHINA: BIOINFORMATICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 149
9.4.2 JAPAN 149
9.4.2.1 Growing focus of Japanese bioinformatics firms on product launches and collaborations to drive growth 149
TABLE 173 JAPAN: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 150
TABLE 174 JAPAN: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 150
TABLE 175 JAPAN: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 150
TABLE 176 JAPAN: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 151
TABLE 177 JAPAN: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION) 151
TABLE 178 JAPAN: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2019–2026 (USD MILLION) 151
TABLE 179 JAPAN: BIOINFORMATICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 152
9.4.3 INDIA 152
9.4.3.1 Preference to outsource pharmaceutical drug discovery to India is a key growth driver 152
TABLE 180 INDIA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 153
TABLE 181 INDIA: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 153
TABLE 182 INDIA: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
TABLE 183 INDIA: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 154
TABLE 184 INDIA: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION) 154
TABLE 185 INDIA: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2019–2026 (USD MILLION) 154
TABLE 186 INDIA: BIOINFORMATICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 155
9.4.4 REST OF ASIA PACIFIC (ROAPAC) 155
TABLE 187 ROAPAC: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 156
TABLE 188 ROAPAC: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 156
TABLE 189 ROAPAC: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 156
TABLE 190 ROAPAC: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 191 ROAPAC: BIOINFORMATICS MARKET, BY SECTOR,
2019–2026 (USD MILLION) 157
TABLE 192 ROAPAC: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY,
BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 193 ROAPAC: BIOINFORMATICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 158
9.5 REST OF THE WORLD 158
TABLE 194 ROW: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,
2019–2026 (USD MILLION) 159
TABLE 195 ROW: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 159
TABLE 196 ROW: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,
2019–2026 (USD MILLION) 159
TABLE 197 ROW: BIOINFORMATICS SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 160
TABLE 198 ROW: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION) 160
TABLE 199 ROW: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2019–2026 (USD MILLION) 160
TABLE 200 ROW: BIOINFORMATICS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 161
10 COMPETITIVE LANDSCAPE 162
10.1 MARKET OVERVIEW 162
FIGURE 20 KEY PLAYERS ADOPTED ORGANIC AND INORGANIC GROWTH STRATEGIES BETWEEN 2018 AND 2021 163
10.2 MARKET RANKING ANALYSIS, 2020 164
FIGURE 21 RANK OF COMPANIES IN THE GLOBAL BIOINFORMATICS MARKET, 2020 164
10.3 COMPANY EVALUATION MATRIX: DEFINITIONS AND METHODOLOGY 165
10.3.1 INTRODUCTION 165
TABLE 201 BIOINFORMATICS MARKET: STRENGTH OF PRODUCT
OFFERINGS FOR COMPANY EVALUATION 165
10.3.2 STARS 165
10.3.3 PERVASIVE PLAYERS 165
10.3.4 EMERGING LEADERS 166
10.3.5 PARTICIPANTS 166
FIGURE 22 BIOINFORMATICS MARKET: GLOBAL COMPETITIVE
LEADERSHIP MAPPING, 2020 166
10.4 COMPETITIVE LEADERSHIP MAPPING: START-UPS/SMES (2020) 167
10.4.1 PROGRESSIVE COMPANIES 167
10.4.2 STARTING BLOCKS 167
10.4.3 RESPONSIVE COMPANIES 167
10.4.4 DYNAMIC COMPANIES 167
FIGURE 23 BIOINFORMATICS MARKET: COMPETITIVE LEADERSHIP MAPPING
FOR START-UPS/SMES, 2020 168
10.5 COMPETITIVE SCENARIO 169
10.5.1 PRODUCT & SERVICE LAUNCHES 169
TABLE 202 BIOINFORMATICS MARKET: PRODUCT & SERVICE LAUNCHES,
JANUARY 2017–MAY 2021 169
10.5.2 EXPANSIONS 169
TABLE 203 BIOINFORMATICS MARKET: EXPANSIONS, JANUARY 2017–MAY 2021 169
10.5.3 DEALS 170
TABLE 204 BIOINFORMATICS MARKET: DEALS, JANUARY 2017–MAY 2021 170
11 COMPANY PROFILES 171
11.1 KEY PLAYERS 171
(Business Overview, Products & Services Offered, Recent Developments, and MnM View)*
11.1.1 THERMO FISHER SCIENTIFIC, INC. 171
TABLE 205 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 171
FIGURE 24 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020) 172
11.1.2 EUROFINS SCIENTIFIC 177
TABLE 206 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW 177
FIGURE 25 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2020) 177
11.1.3 ILLUMINA, INC. 180
TABLE 207 ILLUMINA, INC.: BUSINESS OVERVIEW 180
FIGURE 26 ILLUMINA, INC.: COMPANY SNAPSHOT (2020) 181
11.1.4 PERKIN ELMER, INC. 185
TABLE 208 PERKIN ELMER, INC.: BUSINESS OVERVIEW (2020) 185
FIGURE 27 PERKINELMER, INC.: COMPANY SNAPSHOT (2020) 186
11.1.5 NEOGENOMICS LABORATORIES 188
TABLE 209 NEOGENOMICS LABORATORIES: BUSINESS OVERVIEW 188
FIGURE 28 NEOGENOMICS LABORATORIES: COMPANY SNAPSHOT (2020) 188
11.1.6 QIAGEN N.V. 190
TABLE 210 QIAGEN N.V.: BUSINESS OVERVIEW 190
FIGURE 29 QIAGEN N.V.: COMPANY SNAPSHOT (2020) 191
11.1.7 SOURCE BIOSCIENCE 194
TABLE 211 SOURCE BIOSCIENCE: BUSINESS OVERVIEW 194
FIGURE 30 SOURCE BIOSCIENCE: COMPANY SNAPSHOT (2020) 195
11.1.8 AGILENT TECHNOLOGIES, INC. 197
TABLE 212 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 197
FIGURE 31 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2020) 197
11.1.9 DNASTAR 199
TABLE 213 DNASTAR: BUSINESS OVERVIEW 199
11.1.10 PSOMAGEN, INC. (FORMERLY KNOWN AS MACROGEN CORP.) 201
TABLE 214 PSOMAGEN, INC.: BUSINESS OVERVIEW 201
11.1.11 WATERS CORPORATION 203
TABLE 215 WATERS CORPORATION: BUSINESS OVERVIEW 203
FIGURE 32 WATERS CORPORATION: COMPANY SNAPSHOT (2020) 204
11.1.12 MICROSYNTH 206
TABLE 216 MICROSYNTH: BUSINESS OVERVIEW 206
11.1.13 GENEWIZ (A BROOKS LIFE SCIENCES COMPANY) 208
TABLE 217 GENEWIZ: BUSINESS OVERVIEW 208
11.1.14 MEDGENOME LABS LTD. 210
TABLE 218 MEDGENOME: BUSINESS OVERVIEW 210
11.1.15 PARTEK 211
TABLE 219 PARTEK: BUSINESS OVERVIEW 211
11.1.16 BEIJING GENOMICS INSTITUTE (BGI) 212
TABLE 220 BGI: BUSINESS OVERVIEW 212
11.1.17 BIOMAX INFORMATICS AG 215
TABLE 221 BIOMAX INFORMATICS AG: BUSINESS OVERVIEW 215
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS 216
11.2.1 SOPHIA GENETICS 216
11.2.2 FIOS GENOMICS 217
11.2.3 GENUITY SCIENCE (FORMERLY KNOWN AS WUXI NEXTCODE) 218
11.2.4 PETDX 219
11.2.5 JADBIO 219
11.2.6 BIOSYSTEMS IMMUNOLAB PLC. 220
11.2.7 ASTALAKE BIOSYSTEMS 220
11.2.8 NUCLEOME INFORMATICS PVT. LTD. 221
12 APPENDIX 222
12.1 DISCUSSION GUIDE 222
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 226
12.3 AVAILABLE CUSTOMIZATIONS 228
12.4 RELATED REPORTS 228
12.5 AUTHOR DETAILS 229



★調査レポート[世界のバイオインフォマティクス市場予測(~2026):製品・サービス別、用途別、産業別] ( Bioinformatics Market by Product & Service (Knowledge Management Tools, Data Analysis Platforms, Structural Analysis, Functional Analysis, Services), Applications (Genomics, Proteomics), & Sector (Medical, Animal, Agricultural) – Global Forecast to 2026 / HIT7543) 販売に関する免責事項
[世界のバイオインフォマティクス市場予測(~2026):製品・サービス別、用途別、産業別] ( Bioinformatics Market by Product & Service (Knowledge Management Tools, Data Analysis Platforms, Structural Analysis, Functional Analysis, Services), Applications (Genomics, Proteomics), & Sector (Medical, Animal, Agricultural) – Global Forecast to 2026 / HIT7543) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆